Literature DB >> 2106047

The analysis of lymphocyte surface receptors recognized by wheat germ agglutinin for negative regulation of immune responses in cancer patients.

Y Yamaguchi1, T Toge, N Baba, H Kuninobu, Y Kegoya, T Takayama, T Hattori.   

Abstract

The population of peripheral blood lymphocytes expressing surface receptors for a lectin, wheat germ agglutinin (WGA), which has been shown to recognize the same receptors as the soluble immune suppressor factor (SISF) elaborated from suppressor cells on the lymphocyte surface, was analyzed by using fluorescein isothiocyanate-conjugated WGA on flow cytometry in cancer patients. It was found that the populations of WGA+ lymphocytes in cancer patients were significantly higher than those in either normal volunteers or patients with benign disease and increased with progress of the tumor. The populations decreased after treatment in patients who underwent curative resection of the tumor and in responders of immunochemotherapy but not in those who received non-curative surgery or in non-responders. It was suggested that the increase of receptors for SISF on the lymphocyte surface might play an important role in the negative regulation of immune responses in cancer patients and that WGA might be a useful parameter for immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106047     DOI: 10.1007/bf02470713

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  10 in total

1.  Lymphocyte responsiveness to phytohemagglutinin (PHA) and serum inhibitory effect in patients with gastric cancer.

Authors:  T Toge; H Ikeda; N Senoo; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1976-12

2.  General rule for clinical and histological record of mammary cancer. Japan Mammary Cancer Society.

Authors: 
Journal:  Jpn J Surg       Date:  1975-06

3.  Aggressive natural killer cell leukemia/lymphoma with N901-positive surface phenotype: evidence for the existence of a third lineage in lymphoid cells.

Authors:  N Imamura; Y Kusunoki; H Kajihara; K Okada; A Kuramoto
Journal:  Acta Haematol       Date:  1988       Impact factor: 2.195

4.  Fractionation of human lymphocytes with plant lectins. II. Lens culinaris lectin and wheat germ agglutinin identify distinct lymphocyte subclasses.

Authors:  D H Boldt; R D Lyons
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

5.  Wheat germ agglutinin. Molecular characteristics and specificity for sugar binding.

Authors:  Y Nagata; M M Burger
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

6.  Inhibition of human lymphocyte proliferation by the nonmitogenic lectin wheat germ agglutinin.

Authors:  W C Greene; T A Waldmann
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

7.  Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation.

Authors:  W C Greene; T A Fleisher; T A Waldmann
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

8.  The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.

Authors:  T Kajitani
Journal:  Jpn J Surg       Date:  1981-03

9.  Evidence for an association between CD8 molecules and the T cell receptor complex on cytotoxic T cells.

Authors:  S Takada; E G Engleman
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

10.  Blocking of lymphocyte surface binding sites for the soluble suppressor factor by protein-bound polysaccharide, PSK.

Authors:  T Toge; Y Yamaguchi; Y Kegoya; N Baba; E Yanagawa; T Hattori
Journal:  Int J Immunopharmacol       Date:  1989
  10 in total
  2 in total

Review 1.  Human nonspecific suppressive lymphokines.

Authors:  M T Halpern
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

2.  The role of lymphocyte surface binding sites for wheat germ agglutinin in the negative regulation of cancer patients.

Authors:  T Toge; Y Yamaguchi; A Sawamura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.